nitrendipine has been researched along with Cardiomyopathy, Dilated in 4 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this mouse model of dilated cardiomyopathy leading to sudden arrhythmic death, cardiac structure and function did not significantly differ among the control, cilnidipine, and nitrendipine groups." | 1.40 | Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure. ( Arai, Y; Cho, K; Kamakura, S; Kangawa, K; Kimura, T; Kinoshita, H; Kiyonaka, S; Kuwabara, Y; Kuwahara, K; Minami, T; Mori, Y; Nakagawa, Y; Nakao, K; Nishida, M; Nishikimi, T; Shibata, J; Ueshima, K; Yamada, C; Yamada, Y; Yasuno, S, 2014) |
| "T-type Ca(2+) channel blockade reduced arrhythmias in a mouse model of dilated cardiomyopathy by repolarizing the resting membrane potential and improving cardiac autonomic nervous system imbalance." | 1.35 | T-type Ca2+ channel blockade prevents sudden death in mice with heart failure. ( Arai, Y; Fujiwara, M; Harada, M; Kinoshita, H; Kuwabara, Y; Kuwahara, K; Murakami, M; Nakagawa, Y; Nakanishi, M; Nakao, K; Takano, M; Ueshima, K; Yasuno, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamada, Y | 1 |
| Kinoshita, H | 2 |
| Kuwahara, K | 2 |
| Nakagawa, Y | 2 |
| Kuwabara, Y | 2 |
| Minami, T | 1 |
| Yamada, C | 1 |
| Shibata, J | 1 |
| Nakao, K | 3 |
| Cho, K | 1 |
| Arai, Y | 2 |
| Yasuno, S | 2 |
| Nishikimi, T | 1 |
| Ueshima, K | 2 |
| Kamakura, S | 1 |
| Nishida, M | 1 |
| Kiyonaka, S | 1 |
| Mori, Y | 1 |
| Kimura, T | 1 |
| Kangawa, K | 1 |
| Takano, M | 1 |
| Nakanishi, M | 1 |
| Harada, M | 1 |
| Fujiwara, M | 1 |
| Murakami, M | 1 |
| Rasmussen, RP | 1 |
| Minobe, W | 1 |
| Bristow, MR | 1 |
| Barbieri, L | 1 |
| Mestroni, L | 1 |
| Camerini, F | 1 |
1 review available for nitrendipine and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
[Calcium antagonists in congestive heart failure].
Topics: Calcium Channel Blockers; Cardiomyopathy, Dilated; Diltiazem; Felodipine; Heart Failure; Hemodynamic | 1988 |
3 other studies available for nitrendipine and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nervou | 2014 |
T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
Topics: Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Blood Pressure; Body Weight; Calcium Channe | 2009 |
Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
Topics: Calcium Channel Blockers; Calcium Channels; Cardiomyopathy, Dilated; Cell Membrane; Humans; Iodocyan | 1990 |